Life Science & Medical Technology
Japan's Fujifilm Holdings said Monday that it has won an order to produce a key component of American biotechnology company Novavax's coronavirus vaccine candidate at a site in the U.K.
As scientists the world over scramble to develop a vaccine for the coronavirus, Kyushu University professor Takahiro Kusakabe and his team are working to develop a unique vaccine using silkworms.
Japanese air-conditioner maker Daikin Industries will develop a high-performance reusable medical face mask in cooperation with the National Cerebral and Cardiovascular Center and CrossEffect, a Kyoto-based three-dimensional engineering company.
Japanese drugmaker Shionogi plans to increase production capacity for its coronavirus vaccine candidate, aiming to turn out enough vaccines for 30 million people per year by the end of 2021, as competition intensifies to develop COVID-19 treatments, Nikkei has learned.